TriSalus Life Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for TriSalus Life Sciences (TLSI).

Price Target Range — 8 Quarters

Analyst Consensus — 8 Analysts

8Buy

Consensus RatingBuy# Analysts8Avg. Consensus PT$11Upside to Avg. PT+164.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 23, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$11→$12
Sep 9, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	Initiate	Buy	$11
May 13, 2026	Lake Street	Frank Takkinen	PT Cut	Buy	$10→$8
Mar 9, 2026	Canaccord Genuity	William Plovanic	Maintained	Buy	$7
Mar 6, 2026	Canaccord Genuity	William Plovanic	PT Cut	Buy	$12→$7
Dec 17, 2025	Canaccord Genuity	William Plovanic	PT Raise	Buy	$11→$12
Mar 28, 2025	Canaccord Genuity	William Plovanic	Maintained	Buy	$11
Feb 13, 2025	Lake Street	—	Initiate	Buy	$10
Jan 24, 2025	Roth MKM	Jason Wittes	Maintained	Buy	$11
Dec 17, 2024	Cantor Fitzgerald	Prakhar Agrawal	Initiate	Overweight	$10
Nov 15, 2024	Canaccord Genuity	William Plovanic	PT Cut	Buy	$12→$11
Nov 11, 2024	Roth MKM	Jason Wittes	Initiate	Buy	$11
Oct 25, 2024	Northland Capital Markets	Carl Byrnes	Initiate	Outperform	$13
Sep 16, 2024	Oppenheimer	Suraj Kalia	Initiate	Outperform	$10
Jun 27, 2024	Canaccord Genuity	William Plovanic	Maintained	Buy	$12
May 30, 2024	Canaccord Genuity	William Plovanic	Initiate	Buy	$12
May 10, 2024	JonesTrading	Justin Walsh	Initiate	Buy	$16

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains TriSalus Life Sciences (NASDAQ:TLSI) with a Buy and raises the price target from $11 to $12.

Benzinga Newsdesk

This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiate coverage: Buy ratings for Robinhood ($170), TriSalus ($11), Kodiak AI ($8); Underperform for Deckers ($70).

Avi Kapoor

PRO
HC Wainwright & Co. Initiates Coverage On TriSalus Life Sciences with Buy Rating, Announces Price Target of $11

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on TriSalus Life Sciences (NASDAQ:TLSI) with a Buy rating and announces Price Target of $11.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on TriSalus Life Sciences, Lowers Price Target to $8

Lake Street analyst Frank Takkinen maintains TriSalus Life Sciences (NASDAQ:TLSI) with a Buy and lowers the price target from $10 to $8.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on TriSalus Life Sciences, Lowers Price Target to $7

Canaccord Genuity analyst William Plovanic maintains TriSalus Life Sciences (NASDAQ:TLSI) with a Buy and lowers the price target from $12 to $7.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12

Canaccord Genuity analyst William Plovanic maintains TriSalus Life Sciences (NASDAQ:TLSI) with a Buy and raises the price target from $11 to $12.

Benzinga Newsdesk

TriSalus Life Sciences Inc

TriSalus Life Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12

This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PRO
HC Wainwright & Co. Initiates Coverage On TriSalus Life Sciences with Buy Rating, Announces Price Target of $11

PRO
Lake Street Maintains Buy on TriSalus Life Sciences, Lowers Price Target to $8

PRO
Canaccord Genuity Maintains Buy on TriSalus Life Sciences, Lowers Price Target to $7

PRO
Canaccord Genuity Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12

People Also Watch

People Also Watch

TriSalus Life Sciences Inc

TriSalus Life Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12

This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PROHC Wainwright & Co. Initiates Coverage On TriSalus Life Sciences with Buy Rating, Announces Price Target of $11

PROLake Street Maintains Buy on TriSalus Life Sciences, Lowers Price Target to $8

PROCanaccord Genuity Maintains Buy on TriSalus Life Sciences, Lowers Price Target to $7

PROCanaccord Genuity Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12

PRO
HC Wainwright & Co. Initiates Coverage On TriSalus Life Sciences with Buy Rating, Announces Price Target of $11

PRO
Lake Street Maintains Buy on TriSalus Life Sciences, Lowers Price Target to $8

PRO
Canaccord Genuity Maintains Buy on TriSalus Life Sciences, Lowers Price Target to $7

PRO
Canaccord Genuity Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12